Claim/exemption information - Registry number 3621993

Disclose a statement to the effect that the actual concentration is withheld as a trade secret, where prescribed concentration ranges are used.

Disclose inhalation, ingestion, skin contact and eye contact as likely routes of exposure.

Disclose the HMIRA registry number and correct date of decision granting the exemption, and clearly link which ingredients are part of the subject of the claim for exemption under the HMIRA.

Disclose the common name and synonyms for the ingredients listed in section 3 of the SDS.

Disclose the conditions to avoid.

Disclose the delayed and immediate effects, and chronic effects from short-term and long-term exposure.

Disclose the flammability of the product.

Disclose the information on personal precautions, protective equipment and emergency procedures in section 6 of the SDS.

Disclose the most important symptoms and effects, whether acute or delayed in section 4 of the SDS.

Disclose the reactivity of the product.

Disclose the relevant conditions for safe storage (see appendix 2).

Disclose the relevant first-aid measures (see appendix 1).

Disclose the relevant precautions for safe handling (see appendix 2).

Disclose the restrictions on use.

Disclose the symptoms related to the physical, chemical and toxicological characteristics.

Remove all forward slashes or diagonal marks in precautionary statements for which a choice is to be made.